Please use the Back button to return to your page of origin, or go directly to STD Surveillance 2005 Table of Contents.
Table A4. Government Performance Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures
| GPRA Goals | Baseline 2002 |
Actual Performance | Long-Term Goal 2010 |
||||
| 2004 | 2005 | ||||||
| Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15-44 years of age) | 197,000 | 132,000 | 176,000 | 168,000 | |||
| a. Prevalence of Chlamydia in high-risk women ≤ 25 years | 10.1%* | 9.7%* | 9.2%* | 8.6%* | |||
| b. Prevalence of Chlamydia in women ≤ 25 years in family planning clinics | 5.6%* | 6.3%* | 6.3%* | 4.9%* | |||
| c. Incidence of Gonorrhea/100,000 population in women 15-44 years of age | 279 | 267 | 276 | 237 | |||
| Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population) | 2.4 | 2.7 | 3.0 | 2.2 | |||
| a. Incidence of P&S Syphilis/100,000 population - men | 3.8 | 4.7 | 5.1 | 4.2 | |||
| b. Incidence of P&S Syphilis/100,000 population - women | 1.1 | 0.8 | 0.9 | 0.38 | |||
| c. Incidence of Congenital Syphilis/100,000 live births | 10.2 | 9.1 | 8.0 | 3.9 | |||
| d. Black:white rate ratio of P&S Syphilis | 8:1 | 5.5:1 | 5.4:1 | 3:1 | |||
| GPRA Goals | Data Source |
| 1 | National Disease and Therapeutic Index (IMS Health). |
| 1a | National Job Training Program. |
| 1b | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 1c | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2 | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2a | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2b | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2c | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2d | STD Surveillance System (STDSS), CDC, NCHSTP. |
*Median state-specific chlamydia prevalence among women was not adjusted for
changes in laboratory test method and associated increases in test sensitivity.